Literature DB >> 123038

A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase.

W J Bank, S DiMauro, E Bonilla, D M Capuzzi, L P Rowland.   

Abstract

Two brothers, 29 and 33 years of age, had recurrent myoglobinuria, renal failure and azotemia, but were otherwise normal, without apparent muscle weakness or exercise intolerance. Ischemic exercise resulted in normal lactate production. Muscle glycogen content and activities of phosphorylase and phosphofructokinase were normal. Plasma triglycerides were elevated (500 mg per deciliter) on a regular diet and rose during fasting. During a 72-hour fast, serum creatine phosphokinase rose more than 10 times, and myoglobin was detected in urine. Plasma ketone production was minimal during fasting, but prompt ketonemia ( a normal response) occurred after ingestion of medium-chain triglycerides. Carnitine palmityl transferase activity was virtually absent in crude muscle extracts and mitochondrial fractions. Lack of this enzyme impairs long-chain fatty acid utilization, reflected in increased content of plasma free fatty acids and plasma triglycerides. Depletion of ATP because of this metabolic block in muscle may account for the attacks of myoglobinuria.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123038     DOI: 10.1056/NEJM197502272920902

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 2.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

3.  Potential role of carnitine in patients with renal insufficiency.

Authors:  C Wanner; W H Hörl
Journal:  Klin Wochenschr       Date:  1986-07-01

4.  Reversible changes of the muscle cell in experimental phosphorus deficiency.

Authors:  T J Fuller; N W Carter; C Barcenas; J P Knochel
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

Review 5.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 6.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

7.  Combined partial deficiency of muscle carnitine palmitoyltransferase and carnitine with autosomal dominant inheritance.

Authors:  V Ionasescu; G Hug; C Hoppel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

8.  Acute rhabdomyolysis with carnitine-palmityl-transferase deficiency.

Authors:  P L Blanc; H Carrier; L Thomas; J M Chavaillon; D Robert
Journal:  Intensive Care Med       Date:  1982       Impact factor: 17.440

9.  Myoglobinuria in carnitine palmityltransferase deficiency.

Authors:  D Rowett
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

Review 10.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.